Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

05/02/2014 Award for the T-Systems Data Center located in the Barcelona Synchrotron Park 27/01/2014 Companies from the Barcelona Synchrotron Park will have a privileged access to the ICMAB scientific equipments 20/01/2014 The Catalan Institute of Nanoscience and Nanotechnology opens its new building 14/01/2014 Barcelona, the 4th smartest city in Europe 03/01/2014 The Vall d’Hebron Institut de Recerca becomes a UAB-affiliated research institute 28/11/2013 Visit of a Moscow City Council delegation at Barcelona Synchrotron Park (BSP)
43 44 45 46 47 48 49